Back to Authors

Diehl, Susan

A5008924066 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 2

Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8032-8032

10.1200/jco.2016.34.15_suppl.8032

Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8011-8011

10.1200/jco.2016.34.15_suppl.8011